These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3320601)

  • 21. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
    Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
    Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of arterial hypertension after surgery of the abdominal aorta: comparison of captopril and nifedipine administrated sublingually].
    Leeman M; Degaute JP
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1267-8. PubMed ID: 8129541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of atenolol withdrawal in patients on triple antihypertensive therapy.
    Bevan EG; Pringle SD; Waller PC; Herrick AL; Findlay JG; Murray GD; Carmichael HA; Lorimer AR; Reid JL; Weir RJ
    J Hum Hypertens; 1993 Feb; 7(1):89-93. PubMed ID: 8450527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of sublingual captopril and sublingual nifedipine in hypertensive emergencies.
    Ceyhan B; Karaaslan Y; Caymaz O; Oto A; Oram E; Oram A; Ugurlu S
    Jpn J Pharmacol; 1990 Feb; 52(2):189-93. PubMed ID: 2179605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nifedipine, captopril, metoprolol and nifedipine with metoprolol in hypertensive crisis in non-intensive care setting.
    Karnik ND; Bhatt AD; Trivedi TH; Dadkar VN; Kapadia NM; Vaidya AB; Khokhani RC
    J Assoc Physicians India; 1996 Jul; 44(7):480-2. PubMed ID: 9282610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hypertensive emergencies and crisis with sublingual nifedipine].
    Domínguez B; Díaz R
    Rev Med Panama; 1988 May; 13(2):100-6. PubMed ID: 3194548
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
    Zweifler AJ; Julius S; Nicholls MG
    Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
    J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of Ramadan fasting on ambulatory blood pressure in hypertensive patients using combination drug therapy.
    Ural E; Kozdag G; Kilic T; Ural D; Sahin T; Celebi O; Komsuoglu B
    J Hum Hypertens; 2008 Mar; 22(3):208-10. PubMed ID: 17928875
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
    Deedwania PC
    Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
    Amir M; Cristal N; Bar-On D; Loidl A
    Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of captopril and captopril plus frusemide as antihypertensive agents in non-insulin dependent diabetes.
    Matthews DM; Wathen CG; Bell D; Collier A; Roulston JE; Clarke BF; Muir AL
    J Hum Hypertens; 1987 Jun; 1(1):19-23. PubMed ID: 3334054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of indomethacin and ibuprofen on blood pressure of patients treated with nifedipine or captopril].
    Halawa B
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):313-5. PubMed ID: 8415243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.